LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...
Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...
(MENAFN- GlobeNewsWire - Nasdaq) Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE ...
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.3 per share. This compares to earnings of $2.01 per share a year ago. These ...
Investing.com -- Entera Bio Ltd. (NASDAQ:ENTX) stock rose 3.5% in Thursday’s premarket trading following the company’s presentation of new clinical data from its Phase 2 trial of EB613, an oral ...
Kairos Power and Oak Ridge National Laboratory tested the potential of AM and composites to enable fast, repeatable ...
In a significant boost to Sri Lanka’s agri-tech ambitions, the Lotus Group of Companies has launched the nation’s first private, export-oriented tissue culture laboratory, positioning the island to ...
JERUSALEM, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported new clinical data from a post ...
KUALA LUMPUR - BioNexus Gene Lab Corp (NASDAQ:BGLC), a $9.22 million market cap diagnostics company with annual revenues of $9.55 million, announced Monday it has entered into a non-binding strategic ...
This paper describes Unbend - a new method for measuring and correcting motions in cryo-EM images, with a particular emphasis on more challenging in situ samples such as lamella and whole cells. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results